US 10610534
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
granted A61KA61K31/437A61K31/473
Quick answer
US patent 10610534 (Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency) held by Corcept Therapeutics Incorporated expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/437, A61K31/473, A61K31/513, A61K31/567